GENE ONLINE|News &
Opinion
Blog

2022-04-15|

New Approaches to Effectively Manage Hemophilia in Pregnant Women

by Arvind C. Shekhar
Share To
Hemophilia is a X-linked hereditary bleeding disorder characterized by an absent or decreased coagulation factor VIII (FVIII) in Hemophilia A (HA) or factor IX (FIX) in the case of Hemophilia B (HB). Caused due to a recessive X-chromosomal inheritance pattern, mostly men are affected while their female relatives generally serve as carriers of hemophilia. In terms of numbers, the prevalence of hemophilia is approximately 1 in 5000 males.

It's free! Log in now to read

LOG IN SUBSCRIBE NOW
LATEST
West Nile and Usutu Viruses Detected in Wild Carnivore Populations in the Netherlands
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Biotech Stock Performance Gap Widens During Second Quarter of 2026
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
Penn State College of Medicine Receives $2.5 Million Grant for Street Medicine Program
2026-07-10
READ MORE
EVENT
2026-07-08
ISSCR (Regenerative Medicine &Cell Therapy)
Montreal, Canada
2026-07-15
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
SEE MORE
Scroll to Top